Immunic (IMUX) Other Non Operating Income (2013 - 2026)
Immunic (IMUX) reported Other Non Operating Income of -$113000.0 for Q1 2026, down 109.67% on a YoY basis from $1.2 million in Q1 2025, and down 102.95% sequentially from $3.8 million in Q4 2025.
Immunic (IMUX) Other Non Operating Income (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Other Non Operating Income data on file, last reported at -$113000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 109.67% year-over-year to -$113000.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 68.65% YoY), and the FY2025 full-year result was $5.0 million, up 578.17% from the prior year.
- Other Non Operating Income eased to -$113000.0 in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $3.8 million in Q4 2025 to a low of -$2.1 million in Q1 2024.
- A 5-year average of $260588.2 and a median of $54000.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 277.61% in 2024 and soared 14085.19% in 2025, its largest moves.
- Tracing IMUX's Other Non Operating Income over 5 years: stood at $155000.0 in 2022, then jumped by 718.06% to $1.3 million in 2023, then plunged by 97.87% to $27000.0 in 2024, then soared by 14085.19% to $3.8 million in 2025, then plunged by 102.95% to -$113000.0 in 2026.
- Business Quant data shows IMUX's Other Non Operating Income at -$113000.0 in Q1 2026, $3.8 million in Q4 2025, and -$5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Immunic | 420.10 Mn | 420.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113,000.00 |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 582,000.00 |
| Jun 30, 2024 | 436,000.00 |
| Mar 31, 2024 | -2.09 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | -1.34 Mn |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | 620,000.00 |
| Dec 31, 2021 | 521,000.00 |
| Sep 30, 2021 | -915,000.00 |
| Jun 30, 2021 | 1.22 Mn |